Concepedia

Optimum AT1 receptor-neprilysin inhibition has superior cardioprotective effects compared with AT1 receptor blockade alone in hypertensive rats

Lodi C.W. Roksnoer, Richard van Veghel, René de Vries, Ingrid M. Garrelds, Usha M. Bhaggoe, Edith C. H. Friesema, Frank Leijten, Marko Poglitsch, Oliver Domenig, Marian C. Clahsen‐van Groningen,

Kidney International · 2015 · 48 citations · 43 references

DOIFull text

Open access

Concepts

References

43

Angiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure

John J.V. McMurray, Milton Packer, Akshay S. Desai et al. · New England Journal of Medicine · 2014 · 6.8K citations · Full text

, , +11

Contractile properties of small arterial resistance vessels in spontaneously hypertensive and normotensive rats.

Michael J. Mulvany, W Halpern · Circulation Research · 1977 · 2.1K citations

, , +12

Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene

John J. Mullins, Jörg Peters, Detlev Ganten · Nature · 1990 · 917 citations

, , +16

Angiotensin Receptor Neprilysin Inhibition Compared With Enalapril on the Risk of Clinical Progression in Surviving Patients With Heart Failure

Milton Packer, John J.V. McMurray, Akshay S. Desai et al. · Circulation · 2014 · 667 citations · Full text

, , +16

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study

Luís M. Ruilope, Andrej Dukát, Michael Böhm et al. · The Lancet · 2010 · 592 citations

, , +17